Machine learning-based colistin resistance marker screening and phenotype prediction in Escherichia coli from whole genome sequencing data - 03/02/24
Doi : 10.1016/j.jinf.2023.11.009
Yingxin Tian 1
Department of Laboratory Medicine, The First Medical Centre, Chinese PLA General Hospital, Beijing, China
Di Zhang 1
Department of Laboratory Medicine, Third Xiangya Hospital, Central South University, Changsha, China
∗Correspondence to: Genskey Medical Technology Co., Ltd, Beijing 102206, China.Genskey Medical Technology Co., LtdBeijing102206China
Ying Zhang ⁎ 
Department of Laboratory Medicine, The First Medical Centre, Chinese PLA General Hospital, Beijing, China
∗∗Correspondence to: Chinese PLA General Hospital, Beijing 100853, China.Chinese PLA General HospitalBeijing100853China
Le texte complet de cet article est disponible en PDF.
Plan
© 2023
The British Infection Association. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 88 - N° 2
P. 191-193 - février 2024 Retour au numéro
Article précédent
- Efficacy of SIGMAR1-based therapy in the early treatment of confirmed mild symptomatic COVID-19 patients
- Santiago Grau, José Miguel Vela, Alba Gurt, Jaime Barceló-Vidal, Fabiola Ojeda, Iago López, Laura Gómez-García, María Isabel Loza, Elena Martín-García, Rafael Maldonado, Jordi Monfort, SIGMA Group
- A novel quantitative urine LAM antigen strip for point-of-care tuberculosis diagnosis in non-HIV adults
- Zhen Huang, Huan Huang, Jing Hu, Lu Xia, Xuhui Liu, Rong Qu, Xiaolin Huang, Yang Yang, Kang Wu, Ruiqing Ma, Jinchuan Xu, Zhenyan Chen, Yuhao Wu, Juan Yang, Yong Fang, Jianfeng Zeng, Weihua Lai, Guodong Sui, Wei Sha, Yonghua Xiong, Shuihua Lu, Xiao-Yong Fan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?